Clicky

Sanofi(SNYNF) News

Date Title
Jul 22 Billion euro deal: Sanofi buys UK biotech company to expand respiratory vaccine portfolio
Jul 22 Sanofi to Acquire UK Biotech Vicebio for $1.15 Billion to Bolster Respiratory Vaccine Pipeline
Jul 22 Vicebio, next-generation vaccine biotech, to be acquired by Sanofi for US$1.6 billion
Jul 22 Press Release: Sanofi to acquire Vicebio, expanding respiratory vaccines pipeline
Jul 22 NYC Council's Firewall Starts in District 5--with a Bombshell Named Alina
Jul 21 Sanofi (SNY) Expands Rare Disease Reach With $9.5B Blueprint Deal
Jul 21 SAB Biotherapeutics Raises $175 Million in Oversubscribed Private Placement; Shares Rise Pre-Bell
Jul 21 Sanofi concludes Blueprint Medicines acquisition
Jun 15 Press Release: EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever presented phase 4 head-to-head respiratory study
Jun 15 Dupixent® (dupilumab) Demonstrated Superiority Over Xolair® (Omalizumab) in Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) in Patients with Coexisting Asthma in First-ever Presented Phase 4 Head-to-Head Respiratory Trial
Jun 15 Berenberg Bank Remains a Buy on Sanofi (SNY), Sets a €118 Price Target
Jun 15 Regeneron, Sanofi Announce Positive Dupixent Results for Atopic Dermatitis
Jun 12 Novavax's COVID-Flu Combo Shot Shows Strong Immune Response
Jun 11 Trump Trade: RFK Jr. removes members of vaccine-advising CDC panel
Jun 10 Sanofi (ENXTPA:SAN) Expands Beyfortus RSV Protection Production For Global Demand
Jun 10 Merck Secures FDA Nod for New RSV Antibody Enflonsia in Infants
Jun 9 Sanofi: Information concerning the total number of voting rights and shares - May 2025
Jun 9 Beyfortus Output Tripled As Sanofi, AstraZeneca Scale Up For RSV Season
Jun 9 Regeneron and Sanofi’s dupilumab shows promise in AD trial
Jun 9 Sanofi Appoints James Guy as Country Lead, Canada and General Manager, Specialty Care